Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alain Spatz

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Nature Reviews. Cancer|August 3, 2004
X-chromosome genetics and human cancerAlain Spatz, Christophe Borg, Jean Feunteun
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 15, 2004
Soft tissue sarcomas. Case 3. Gastrointestinal stromal tumor and Carney's triadAlain Spatz, Brigitte Bressac-de-Paillerets, Eric Raymond
Archives of Dermatology|July 23, 2008
Prospective study of the cutaneous adverse effects of sorafenib, a novel multikinase inhibitorJulien Autier, Bernard Escudier, Janine Wechsler, et al.
Journal of the American Academy of Dermatology|November 26, 2008
Dermatologic symptoms associated with the multikinase inhibitor sorafenibCaroline Robert, Christina Mateus, Alain Spatz, et al.
Future Oncology (London, England)|November 29, 2007
Expression profiling of melanoma cell lines: in search of a progression-related molecular signatureJoost J Van den Oord, Alain Sarasin, Vèronique Winnepenninckx, et al.
The Journal of Pathology|May 17, 2002
Identification of histological features associated with metastatic potential in thin (<1.0 mm) cutaneous melanoma with metastases. A study on behalf of the EORTC Melanoma GroupMartin G Cook, Alain Spatz, Eva-Bettina Bröcker, et al.
Lancet (London, England)|March 28, 2003
Tyrosine kinase inhibition and grey hairCaroline Robert, Alain Spatz, Sandrine Faivre, et al.
Journal of Cutaneous Pathology|March 17, 2005
The importance of mitotic rate as a prognostic factor for localized cutaneous melanomaRaymond L Barnhill, Jason Katzen, Alain Spatz, et al.
Journal of the National Cancer Institute|March 18, 2004
Is systemic disease in the coelomic epithelium associated with BRCA1 germline mutations?Patricia Pautier, Philippe Morice, Suzette Delaloge, et al.
European Journal of Cancer (Oxford, England : 1990)|February 23, 2002
The role of the EORTC pathologist in clinical trials: achievements and perspectives. European Organisation for Research and Treatment of CancerAlain Spatz, Dirk J Ruiter, Christen Busch, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Nature Reviews. Cancer|August 3, 2004
X-chromosome genetics and human cancerAlain Spatz, Christophe Borg, Jean Feunteun
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 15, 2004
Soft tissue sarcomas. Case 3. Gastrointestinal stromal tumor and Carney's triadAlain Spatz, Brigitte Bressac-de-Paillerets, Eric Raymond
Archives of Dermatology|July 23, 2008
Prospective study of the cutaneous adverse effects of sorafenib, a novel multikinase inhibitorJulien Autier, Bernard Escudier, Janine Wechsler, et al.
Journal of the American Academy of Dermatology|November 26, 2008
Dermatologic symptoms associated with the multikinase inhibitor sorafenibCaroline Robert, Christina Mateus, Alain Spatz, et al.
Future Oncology (London, England)|November 29, 2007
Expression profiling of melanoma cell lines: in search of a progression-related molecular signatureJoost J Van den Oord, Alain Sarasin, Vèronique Winnepenninckx, et al.
The Journal of Pathology|May 17, 2002
Identification of histological features associated with metastatic potential in thin (<1.0 mm) cutaneous melanoma with metastases. A study on behalf of the EORTC Melanoma GroupMartin G Cook, Alain Spatz, Eva-Bettina Bröcker, et al.
Lancet (London, England)|March 28, 2003
Tyrosine kinase inhibition and grey hairCaroline Robert, Alain Spatz, Sandrine Faivre, et al.
Journal of Cutaneous Pathology|March 17, 2005
The importance of mitotic rate as a prognostic factor for localized cutaneous melanomaRaymond L Barnhill, Jason Katzen, Alain Spatz, et al.
Journal of the National Cancer Institute|March 18, 2004
Is systemic disease in the coelomic epithelium associated with BRCA1 germline mutations?Patricia Pautier, Philippe Morice, Suzette Delaloge, et al.
European Journal of Cancer (Oxford, England : 1990)|February 23, 2002
The role of the EORTC pathologist in clinical trials: achievements and perspectives. European Organisation for Research and Treatment of CancerAlain Spatz, Dirk J Ruiter, Christen Busch, et al.
Pageof 5